Keywords: global, hepatitis, market, set, reach, billion, worldwide
Global hepatitis market "set to reach $3.97 billion by 2007"
Article | 01 July 2002
The worldwide market for hepatitis C therapeutics is expected to reachnearly $4 billion by 2007, driven by a growing patient population and ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Is failure to adopt business process management putting the pharma industry at risk?
- Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
